Business
A Once-a-Week Insulin Clears a Key UK Hurdle for NHS Use
NICE has backed Eli Lilly’s Onswik, a weekly insulin injection, for type 2 diabetes — cutting jabs by about 85% for patients who struggle with daily dosing, pending final approval.